Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic.

Grossberg, Laurie B; Pellish, Randall S; Cheifetz, Adam S; Feuerstein, Joseph D

Grossberg, Laurie B; Pellish, Randall S; Cheifetz, Adam S; Feuerstein, Joseph D.

Grossberg LB; Lahey Hospital and Medical Center, Tufts Medical School, Burlington, Massachusetts.
Pellish RS; Lahey Hospital and Medical Center, Tufts Medical School, Burlington, Massachusetts.
Cheifetz AS; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Feuerstein JD; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Inflamm Bowel Dis ; 27(6): 940-946, 2021 05 17.

Article in English | MEDLINE | ID: covidwho-632021

Subject(s)

COVID-19/prevention & control; Gastroenterology/standards; Infection Control/standards; Inflammatory Bowel Diseases/therapy; Practice Guidelines as Topic; Colitis, Ulcerative/therapy; Crohn Disease/therapy; Disease Management; Humans; SARS-CoV-2; Societies, Medical/standards

Keywords

COVID-19; Crohn disease; coronavirus; inflammatory bowel disease; ulcerative colitis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Infection Control / Practice Guidelines as Topic / Gastroenterology / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Inflamm Bowel Dis Journal subject: Gastroenterology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google